• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌生存的全球模式与趋势:基于人群登记数据的系统综述

Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.

作者信息

Jiang Yufei, Yuan Huiyun, Li Zhuoying, Ji Xiaowei, Shen Qiuming, Tuo Jiayi, Bi Jinghao, Li Honglan, Xiang Yongbing

机构信息

State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

出版信息

Cancer Biol Med. 2021 Sep 6;19(2):175-86. doi: 10.20892/j.issn.2095-3941.2020.0634.

DOI:10.20892/j.issn.2095-3941.2020.0634
PMID:34486877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8832952/
Abstract

This review will describe the global patterns and trends of colorectal cancer survival, using data from the population-based studies or cancer registration. We performed a systematic search of China National Knowledge Infrastructure (CNKI), Wanfang Data, PubMed, Web of Science, EMBASE, and SEER and collected all population-based survival studies of colorectal cancer (up to June 2020). Estimates of observed and relative survival rates of colorectal cancer by sex, period, and country were extracted from original studies to describe the temporal patterns and trends from the late 1990s to the early 21st century. Globally, 5-year observed survival rates were higher in Seoul, Republic of Korea (1993-1997; 56.8% and 54.3% for colon and rectum cancers, respectively), Zhejiang province (2005-2010; 52.9% for colon cancer), Tianjin (1991-1999; 52.5% for colon cancer), Shanghai (2002-2006; 50.0% for rectum cancer) of China, and in Japan (1993-1996, 59.6% for colorectal cancer). Five-year relative survival rates of colorectal cancer in the Republic of Korea (2010-2014), Queensland, Australia (2005-2012), and the USA (2005-2009) ranked at relatively higher positions compared to other countries. In general, colorectal cancer survival rates are improving over time worldwide. Sex disparities in survival rates were also observed in the colon, rectum, and colorectal cancers in most countries or regions. The poorest age-specific 5-year relative survival rate was observed in patients > 75 years of age. In conclusion, over the past 3 decades, colorectal cancer survival has gradually improved. Geographic variations, sex differences, and age gradients were also observed globally in colorectal cancer survival. Further studies are therefore warranted to investigate the prognostic factors of colorectal cancer.

摘要

本综述将利用基于人群的研究或癌症登记数据,描述结直肠癌生存的全球模式和趋势。我们对中国知网(CNKI)、万方数据、PubMed、Web of Science、EMBASE和监测、流行病学与最终结果(SEER)进行了系统检索,并收集了所有基于人群的结直肠癌生存研究(截至2020年6月)。从原始研究中提取按性别、时期和国家划分的结直肠癌观察生存率和相对生存率估计值,以描述从20世纪90年代末到21世纪初的时间模式和趋势。在全球范围内,韩国首尔(1993 - 1997年;结肠癌和直肠癌的5年观察生存率分别为56.8%和54.3%)、中国浙江省(2005 - 2010年;结肠癌为52.9%)、天津(1991 - 1999年;结肠癌为52.5%)、上海(2002 - 2006年;直肠癌为50.0%)以及日本(1993 - 1996年,结直肠癌为59.6%)的5年观察生存率较高。与其他国家相比,韩国(2010 - 2014年)、澳大利亚昆士兰州(2005 - 2012年)和美国(2005 - 2009年)的结直肠癌5年相对生存率排名相对较高。总体而言,全球范围内结直肠癌生存率随时间推移有所提高。在大多数国家或地区,结肠癌、直肠癌和结直肠癌的生存率也存在性别差异。在75岁以上的患者中观察到最差的年龄特异性5年相对生存率。总之,在过去30年中,结直肠癌生存率逐渐提高。在全球范围内,结直肠癌生存也存在地理差异、性别差异和年龄梯度。因此,有必要进一步研究结直肠癌的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/0e494249b098/cbm-19-175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/b0ed72ca034d/cbm-19-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/4570ad17a54c/cbm-19-175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/0e494249b098/cbm-19-175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/b0ed72ca034d/cbm-19-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/4570ad17a54c/cbm-19-175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/8832952/0e494249b098/cbm-19-175-g003.jpg

相似文献

1
Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.结直肠癌生存的全球模式与趋势:基于人群登记数据的系统综述
Cancer Biol Med. 2021 Sep 6;19(2):175-86. doi: 10.20892/j.issn.2095-3941.2020.0634.
2
Observed and relative survival trends of lung cancer: A systematic review of population-based cancer registration data.肺癌观察生存率和相对生存率趋势:基于人群的癌症登记数据的系统评价。
Thorac Cancer. 2024 Jan;15(2):142-151. doi: 10.1111/1759-7714.15170. Epub 2023 Nov 20.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Trends of stomach cancer survival: A systematic review of survival rates from population-based cancer registration.胃癌生存率趋势:基于人群癌症登记的生存率系统评价
J Dig Dis. 2022 Jan;23(1):22-32. doi: 10.1111/1751-2980.13070. Epub 2022 Jan 17.
5
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.膳食纤维用于预防复发性结直肠腺瘤和癌。
Cochrane Database Syst Rev. 2017 Jan 8;1(1):CD003430. doi: 10.1002/14651858.CD003430.pub2.

引用本文的文献

1
Description and disposition of home patients with colorectal cancer accessing a practical, complications related medication therapy management service.对接受实用的、与并发症相关的药物治疗管理服务的结直肠癌居家患者的描述与处置。
Front Oncol. 2025 Jul 17;15:1595010. doi: 10.3389/fonc.2025.1595010. eCollection 2025.
2
Theabrownin combined with zearalenone suppresses colitis-associated colorectal cancer by inhibiting PI3K/AKT pathway and enhancing microbial propionate production.茶褐素与玉米赤霉烯酮联合通过抑制PI3K/AKT通路和增强微生物丙酸生成来抑制结肠炎相关的结直肠癌。
Sci Rep. 2025 Jul 21;15(1):26386. doi: 10.1038/s41598-025-11820-2.
3

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Changes in survival of colorectal cancer patients in Świętokrzyskie Province (Southern Poland) from the second half of the 1990s to the early 21st century - a population-based study.20世纪90年代后半期至21世纪初波兰南部什切青省结直肠癌患者生存率的变化——一项基于人群的研究。
Ann Agric Environ Med. 2020 Jun 19;27(2):301-305. doi: 10.26444/aaem/106042. Epub 2019 Apr 9.
3
Risk Factors of Multiple Primary Cancers Among Colorectal Cancer Survivors.
结直肠癌幸存者中多原发性癌症的危险因素
Cancers (Basel). 2025 Jun 25;17(13):2145. doi: 10.3390/cancers17132145.
4
Colorectal Cancer and the Risk of Mortality Among Individuals with Suicidal Ideation.结直肠癌与有自杀意念个体的死亡风险
Int J Environ Res Public Health. 2025 May 30;22(6):862. doi: 10.3390/ijerph22060862.
5
Gene Swin transformer: new deep learning method for colorectal cancer prognosis using transcriptomic data.基因斯温变换器:一种利用转录组数据预测结直肠癌预后的新型深度学习方法。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf275.
6
A tumor-microvessel on-a-chip reveals a mechanism for cancer cell cluster intravasation.一种芯片上的肿瘤微血管揭示了癌细胞簇内渗的机制。
iScience. 2025 Apr 24;28(6):112517. doi: 10.1016/j.isci.2025.112517. eCollection 2025 Jun 20.
7
Performance Comparison of Droplet Digital PCR and Next-Generation Sequencing for Circulating Tumor DNA Detection in Non-Metastatic Rectal Cancer.液滴数字PCR与下一代测序技术在非转移性直肠癌循环肿瘤DNA检测中的性能比较
Cancer Med. 2025 May;14(9):e70943. doi: 10.1002/cam4.70943.
8
Clonal dispersal is associated with tumor heterogeneity and poor prognosis in colorectal cancer.克隆性扩散与结直肠癌的肿瘤异质性和不良预后相关。
iScience. 2025 Apr 10;28(5):112403. doi: 10.1016/j.isci.2025.112403. eCollection 2025 May 16.
9
A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice.一种用于共递送抗程序性死亡配体1(anti-PD-L1)和阿霉素以治疗小鼠结肠癌的蛋白酶可裂解脂质体。
Nat Commun. 2025 Mar 24;16(1):2854. doi: 10.1038/s41467-025-57965-6.
10
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors.靶向胃肠道癌症中的NEK激酶:对基因表达、功能及抑制剂的见解
Int J Mol Sci. 2025 Feb 25;26(5):1992. doi: 10.3390/ijms26051992.
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
帕尼单抗单药维持治疗与帕尼单抗联合氟尿嘧啶-亚叶酸钙用于RAS野生型转移性结直肠癌患者的疗效比较:一项2期随机临床试验
JAMA Oncol. 2019 Sep 1;5(9):1268-1275. doi: 10.1001/jamaoncol.2019.1467.
4
Health Insurance and Colorectal Cancer Survival in Khon Kaen, Thailand.泰国孔敬府的健康保险与结直肠癌生存率
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1797-1802. doi: 10.31557/APJCP.2019.20.6.1797.
5
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016.《韩国癌症统计:2016 年发病率、死亡率、生存率和流行率》
Cancer Res Treat. 2019 Apr;51(2):417-430. doi: 10.4143/crt.2019.138. Epub 2019 Mar 18.
6
Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data.基于韩国中央癌症登记数据的韩国结直肠癌患者的特征与生存情况
Ann Coloproctol. 2018 Aug;34(4):212-221. doi: 10.3393/ac.2018.08.02.1. Epub 2018 Aug 31.
7
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.2003-2015 年期间中国癌症生存率变化:基于 17 个癌症登记处的汇总分析。
Lancet Glob Health. 2018 May;6(5):e555-e567. doi: 10.1016/S2214-109X(18)30127-X.
8
Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.爱沙尼亚实施筛查之前特定亚部位和分期的结直肠癌发病趋势
Cancer Epidemiol. 2018 Feb;52:112-119. doi: 10.1016/j.canep.2017.12.016. Epub 2018 Jan 4.
9
Spatial variation in cancer incidence and survival over time across Queensland, Australia.澳大利亚昆士兰州癌症发病率和生存率随时间的空间变化。
Spat Spatiotemporal Epidemiol. 2017 Nov;23:59-67. doi: 10.1016/j.sste.2017.09.002. Epub 2017 Oct 5.
10
Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.西班牙成年癌症患者的生存情况。九个基于人群的癌症登记处的结果。
Clin Transl Oncol. 2018 Feb;20(2):201-211. doi: 10.1007/s12094-017-1710-6. Epub 2017 Jul 17.